Advertisement
U.S. markets closed

Terns Pharmaceuticals, Inc. (TERN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
5.79+0.08 (+1.40%)
At close: 04:00PM EST
5.80 +0.01 (+0.17%)
After hours: 06:13PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close5.71
Open5.71
Bid5.76 x 200
Ask5.81 x 300
Day's Range5.54 - 5.84
52 Week Range3.68 - 11.40
Volume834,156
Avg. Volume1,998,925
Market Cap491.796M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.18
Earnings DateNov 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.19
  • GlobeNewswire

    Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors

    Accomplished biotechnology CEO brings 25 years of strategic, operational, and legal experienceFOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced the appointment of Heather Turner, J.D., former Chief Executive Officer at Carmot Therapeutics, Inc.

  • Simply Wall St.

    We Think Terns Pharmaceuticals (NASDAQ:TERN) Can Afford To Drive Business Growth

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...